Sheldon Koenig

Sheldon Koenig

Directeur Général chez ESPERION THERAPEUTICS, INC.
60 ans
Health Technology
Consumer Services

Profil

Sheldon L.
Koenig
is the founder of Nuvig Therapeutics, Inc. Mr. Koenig is President & Chief Executive Officer at Esperion Therapeutics, Inc. since 2026.
Formerly, Mr. Koenig was Vice President at Merck & Co., Inc. from 2009 to 2015.
Mr. Koenig was Chief Commercial Officer & Executive VP at Portola Pharmaceuticals LLC from 2019 to 2020.
Mr. Koenig was Senior VP & Head-Cardiovascular Franchise at Sanofi Corp.
Education includes an undergraduate degree from Drexel University and an MBA from Monmouth University.

Postes actifs de Sheldon Koenig

SociétésPosteDébut
ESPERION THERAPEUTICS, INC. Directeur Général 18/05/2021

Anciens postes connus de Sheldon Koenig

SociétésPosteFin
PORTOLA PHARMACEUTICALS, INC. Corporate Officer/Principal 01/08/2020
MERCK & CO., INC. Corporate Officer/Principal 01/01/2015
Fondateur -
Corporate Officer/Principal -
Voir l'expérience en détail de Sheldon Koenig

Formation de Sheldon Koenig

Expériences
Fonctions occupées

Actives

Inactives

Sociétés cotées

Entreprise privées

Relations

78

Relations au 1er degré

7

Entreprises liées au 1er degré

Homme

Femme

Administrateurs

Exécutifs

Sociétés liées

Entreprise privées7

Health Technology

Health Technology

Health Technology

Consumer Services

Consumer Services

Health Technology

Health Technology

  1. Bourse
  2. Insiders
  3. Sheldon Koenig
🔇